Contributors

Contributors Mysteries have always appealed to Manel Esteller, a self-proclaimed “aficionado” of Sherlock Holmes. “I like the possibility to deduce a whole starting from a minimal clue.” Trying to solve the mystery surrounding the molecular genetics of endometrial carcinoma during his PhD program at Universidad de Barcelona led him to devote himself to epigenetics, after he found that pure genetics was unable to explain his results. He move

Written byThe Scientist
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Mysteries have always appealed to Manel Esteller, a self-proclaimed “aficionado” of Sherlock Holmes. “I like the possibility to deduce a whole starting from a minimal clue.” Trying to solve the mystery surrounding the molecular genetics of endometrial carcinoma during his PhD program at Universidad de Barcelona led him to devote himself to epigenetics, after he found that pure genetics was unable to explain his results. He moved to the United States for a postdoc at Johns Hopkins University in Baltimore, studying DNA methylation’s role in human cancer, and in 2001 founded Spain’s first epigenetics lab. He is the Director of the Cancer Epigenetics and Biology Program of the Bellvitge Institute for Biomedical Research in Barcelona, but relishes spending his free time with his family, including his six-and-a-half-year-old son. “A lot of developmental epigenetic changes are occurring in him while he is growing so fast!” Esteller describes how epigenetics has broadened ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies